Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).
Geller DS, Morris J, Revskaya E, Kahn M, Zhang W, Piperdi S, Park A, Koirala P, Guzik H, Hall C, Hoang B, Yang R, Roth M, Gill J, Gorlick R, Dadachova E.
Geller DS, et al. Among authors: revskaya e.
Nucl Med Biol. 2016 Dec;43(12):812-817. doi: 10.1016/j.nucmedbio.2016.07.008. Epub 2016 Jul 30.
Nucl Med Biol. 2016.
PMID: 27744117
Free PMC article.